Clinical Trial Update: Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib [Phase 2]

View source ↗

Summary

Phase 2 trial comparing dasatinib to imatinib in patients with chronic phase chronic myeloid leukemia who did not respond favorably to imatinib; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Phase Chronic Myeloid Leukemia

Drugs mentioned

• DASATINIB (Dasatinib)
• Imatinib (imatinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Chronic Phase Chronic Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-04-11